Technologies for imaging the pathophysiology of Alzheimer disease (AD) now permit
studies of the relationships between the two major proteins deposited in this disease …

Alzheimer's disease (AD) is a degenerative neurological disease in elderly individuals.
Subjective cognitive decline (SCD), mild cognitive impairment (MCI) and further …

Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …

Abstract Introduction The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued
development and standardization of methodologies for biomarkers and has provided an …

Preterm infants are at high risk of neurodevelopmental impairment, which may be due to
altered development of brain connectivity. We aimed to (i) assess structural brain …

Studies have demonstrated that the clinical manifestations of Alzheimer's disease (AD) are
associated with abnormal connections in either functional connectivity networks (FCNs) or …

It is well known that most brain disorders are complex diseases, such as Alzheimer's
disease (AD) and schizophrenia (SCZ). In general, brain regions and their interactions can …

Alzheimer's disease (AD) has a preclinical phase that can last for decades prior to clinical
dementia onset. Subjective cognitive decline (SCD) is regarded as the last preclinical AD …

Background Subjective cognitive decline (SCD) is a preclinical stage along the Alzheimer's
disease (AD) continuum. However, little is known about the aberrant patterns of connectivity …

Purpose To determine whether individuals with subjective cognitive decline (SCD), which is
defined by memory complaints with normal performance at objective neuropsychologic …